Literature DB >> 3415432

Persistence of haloperidol in the brain.

B M Cohen, S Babb, A Campbell, R J Baldessarini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3415432     DOI： 10.1001/archpsyc.1988.01800330113019

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  7 in total

Review 1.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

2.  Region specific distribution of levomepromazine in the human brain.

Authors:  J Kornhuber; H Weigmann; J Röhrich; J Wiltfang; S Bleich; I Meineke; R Zöchling; S Härtter; P Riederer; C Hiemke
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 3.  Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report.

Authors:  Mina Fukai; Tetsu Hirosawa; Tetsuya Takahashi; Reizo Kaneda; Mitsuru Kikuchi; Yoshio Minabe
Journal:  Ther Adv Psychopharmacol       Date:  2016-12-02

4.  Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.

Authors:  B M Cohen; T Tsuneizumi; R J Baldessarini; A Campbell; S M Babb
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats.

Authors:  A V Terry; D A Gearhart; S Warner; E J Hohnadel; M-L Middlemore; G Zhang; M G Bartlett; S P Mahadik
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

6.  Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.

Authors:  L E van Beijsterveldt; R J Geerts; J E Leysen; A A Megens; H M Van den Eynde; W E Meuldermans; J J Heykants
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 7.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.